🇺🇸 FDA
Patent

US 7476535

TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes

granted A61KA61K2039/53A61K2239/31

Quick answer

US patent 7476535 (TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/53, A61K2239/31, A61K2239/38, A61K2239/57